Cuproptosis-Related lncRNAs Modulate the Prognosis of MIBC by Regulating the Expression Pattern of Immunosuppressive Molecules Within the Tumor Microenvironment
Huangqi Duan,Yu Shen,Chen Wang,Weimin Xia,Shun Zhang,Shenggen Yu,Ding Xu,Qifeng Cao,Hailong Liu,Haibo Shen
DOI: https://doi.org/10.2147/ijgm.s438501
IF: 2.145
2024-01-20
International Journal of General Medicine
Abstract:Huangqi Duan, &ast Yu Shen, &ast Chen Wang, Weimin Xia, Shun Zhang, Shenggen Yu, Ding Xu, Qifeng Cao, Hailong Liu, Haibo Shen Department of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hailong Liu; Haibo Shen, Department of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China, Email ; Background: Cuproptosis-related gene and long non-coding RNA (lncRNA) modulation of cancer regulation is well-established. This investigation aimed to elucidate the prognostic implications of cuproptosis-associated lncRNAs in muscle-invasive bladder cancer (MIBC). Methods: Employing the Cancer Genome Atlas (TCGA) and IMvigor210 cohorts, bioinformatics and statistical analyses probed the prognostic relevance of cuproptosis-related lncRNAs. Results: Co-expression analysis revealed tight associations between lncRNA expression and cuproptosis-linked genes, with 13 cuproptosis-related lncRNAs found to correlate with MIBC prognosis. Lasso regression identified a six-lncRNA prognostic signature, enabling patient stratification into high- and low-risk categories. Tissue validation substantiated differential expression of FAM13A-AS1, GHRLOS, LINC00456, OPA1-AS1, RAP2C-AS1, and UBE2Q1-AS1 between MIBC tumor and normal tissues. Comparative analyses of tumor microenvironments and immune profiles between risk groups disclosed elevated immunosuppressive molecule expression, including programmed cell death-1 (PD-L1) and T-cell immunoglobulin-3 (TIM-3), in high-risk individuals. Conclusion: These findings suggest that cuproptosis-related lncRNAs may modulate the expression of immunosuppressive molecules, thereby influencing MIBC tumorigenesis and progression. Further exploration is warranted to unveil novel therapeutic targets for MIBC based on the expression patterns of cuproptosis-related lncRNAs and their impact on immune responses in the tumor microenvironment. Keywords: cuproptosis-related lncRNAs, immunosuppressive molecules, MIBC, prognostic, risk scores Bladder carcinoma (BLCA) ranks among the top ten most prevalent and costly cancers globally, accounting for approximately 550,000 new cases annually and significant morbidity and mortality. 1,2 Muscle-invasive bladder cancer (MIBC) is initially diagnosed in 25% of patients, while 10–20% of non-muscle invasive bladder cancer (NMIBC) cases progress to MIBC. 3 Despite advancements in surgical and treatment modalities, MIBC prognosis remains poor, with a 5-year post-therapy survival rate of 40%-60%. 4,5 Investigating MIBC development mechanisms and identifying prognostic biomarkers are vital for enhancing patient outcomes and tailoring postoperative treatment strategies. Cuproptosis, a recently discovered form of programmed cell death, involves copper, an essential cofactor in enzymatic activity and physiological homeostasis. 6–9 Previous studies have shown that c opper induces tumor cell death, inhibits tumor progression, contributes to proteotoxic stress, impedes proteasomes, and promotes anti-angiogenesis. 10–12 However, few studies have explored the BLCA microenvironment or its biological functions, warranting further investigation into cuproptosis' relationship with BLCA development and progression. In the meantime, long non-coding RNA (lncRNA) dysregulation is associated with various tumor types, 13,14 but the complete role of cuproptosis-related gene regulatory factors in lncRNA regulation remains unclear. Uncovering the mechanisms by which cuproptosis-related gene modification influences MIBC development may reveal potential therapeutic targets. Using The Cancer Genome Atlas (TCGA) and IMvigor210 cohorts, we analyzed MIBC patient data to determine the prognostic significance of cuproptosis-related lncRNA. Our findings indicated that six cuproptosis-related lncRNAs possess prognostic value in MIBC patients, and we constructed a prognostic signature based on their ability to predict overall survival. Crucially, our study suggests that cuproptosis-related lncRNA modulates immunosuppressive molecule expression, impacting MIBC prognosis. Ten pairs of fresh tumor tissue samples from MIBC patients and paired normal tissue samples were collected at the Xinhua Hospital Affiliated Shanghai Jiao Tong University School of Medicine. This research was approved by the Medical Ethics Committee of Xinhua Hospital of Affiliated Shanghai Jiao Tong University School of Medicine and informed consent was obtained from all patients. The study complies with the Declaration of Helsinki. Total RNA was isolated from tissues using -Abstract Truncated-
medicine, general & internal